Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.

Wong SH, Happy C, Blinka D, Gock S, Jentzen JM, Donald Hon J, Coleman H, Jortani SA, Lucire Y, Morris-Kukoski CL, Neuman MG, Orsulak PJ, Sander T, Wagner MA, Wynn JR, Wu AH, Yeo KT.

Pharmacogenomics. 2010 Jun;11(6):731-7. doi: 10.2217/pgs.10.63. No abstract available.

2.

Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.

Keck PE, Orsulak PJ, Cutler AJ, Sanchez R, Torbeyns A, Marcus RN, McQuade RD, Carson WH; CN138-135 Study Group.

J Affect Disord. 2009 Jan;112(1-3):36-49. doi: 10.1016/j.jad.2008.05.014. Epub 2008 Oct 2.

PMID:
18835043
3.

Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.

Edwards S, Whisler KN, Fuller DC, Orsulak PJ, Self DW.

Neuropsychopharmacology. 2007 Feb;32(2):354-66. Epub 2006 Mar 15.

4.

Lamotrigine in patients with bipolar disorder and cocaine dependence.

Brown ES, Nejtek VA, Perantie DC, Orsulak PJ, Bobadilla L.

J Clin Psychiatry. 2003 Feb;64(2):197-201.

PMID:
12633129
5.

Doxepin plasma concentrations: is there really a therapeutic range?

Leucht S, Steimer W, Kreuz S, Abraham D, Orsulak PJ, Kissling W.

J Clin Psychopharmacol. 2001 Aug;21(4):432-9.

PMID:
11476128
6.
7.

Prehospital stability of diazepam and lorazepam.

Gottwald MD, Akers LC, Liu PK, Orsulak PJ, Corry MD, Bacchetti P, Fields SM, Lowenstein DH, Alldredge BK.

Am J Emerg Med. 1999 Jul;17(4):333-7.

PMID:
10452426
8.

Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome.

Gurguis GN, Blakeley JE, Antai-Otong D, Vo SP, Orsulak PJ, Petty F, Rush AJ.

J Psychiatr Res. 1999 Jul-Aug;33(4):309-22. Review.

PMID:
10404469
9.

Characteristics of norepinephrine and clonidine displacement of [3H]yohimbine binding to platelet alpha2-adrenoreceptors in healthy volunteers.

Gurguis GN, Vo SP, Blakeley J, Orsulak PJ, Rush AJ.

Psychiatry Res. 1999 Mar 22;85(3):305-14.

PMID:
10333382
10.

Neutrophil beta2-adrenergic receptor coupling efficiency to Gs protein in subjects with post-traumatic stress disorder and normal controls.

Gurguis GN, Andrews R, Antai-Otong D, Vo SP, Blakeley JE, Orsulak PJ, Rush AJ.

Psychopharmacology (Berl). 1999 Apr;143(2):131-40.

PMID:
10326775
11.

Effects of fluoxetine on the polysomnogram in outpatients with major depression.

Trivedi MH, Rush AJ, Armitage R, Gullion CM, Grannemann BD, Orsulak PJ, Roffwarg HP.

Neuropsychopharmacology. 1999 May;20(5):447-59.

12.

Platelet alpha2-adrenergic receptor coupling efficiency to Gi protein in subjects with post-traumatic stress disorder and normal controls.

Gurguis GN, Andrews R, Antai-Otong D, Vo SP, Dikis EJ, Orsulak PJ, Rush AJ.

Psychopharmacology (Berl). 1999 Jan;141(3):258-66.

PMID:
10027507
13.

Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome.

Gurguis GN, Antai-Otong D, Vo SP, Blakeley JE, Orsulak PJ, Petty F, Rush AJ.

Neuropsychopharmacology. 1999 Feb;20(2):162-76.

14.

Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.

Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Weissenburger JE, Fulton CL, Fairchild CJ, Roffwarg HP.

Biol Psychiatry. 1997 May 1;41(9):915-28.

PMID:
9110097
15.

The dexamethasone suppression test in patients with mood disorders.

Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker CR Jr, Weissenburger JE, Crowley GT, Khatami M, Vasavada N.

J Clin Psychiatry. 1996 Oct;57(10):470-84. Review.

PMID:
8909334
16.

Growth hormone response to baclofen: a comparison of 10-mg and 20-mg doses in healthy men.

Davis LL, Trivedi M, Kramer GL, Rush AJ, Orsulak PJ, Akers L, Petty F.

Psychiatry Res. 1996 Feb 28;60(1):41-7.

PMID:
8852867
17.

Plasma GABA predicts acute response to divalproex in mania.

Petty F, Rush AJ, Davis JM, Calabrese JR, Kimmel SE, Kramer GL, Small JG, Miller MJ, Swann AE, Orsulak PJ, Blake ME, Bowden CL.

Biol Psychiatry. 1996 Feb 15;39(4):278-84.

PMID:
8645774
18.

Depression spectrum disease with and without depression in first-degree relatives.

Rush AJ, Feldman-Koffler F, Weissenburger JE, Giles DE, Roffwarg HP, Orsulak PJ.

J Affect Disord. 1995 Dec 13;35(3):131-8.

PMID:
8749841
19.

Arecoline reverses dexamethasone suppression of cortisol in normal males: a pilot study.

Charles GA, Orsulak PJ, Rush AJ, Fulton CL.

Biol Psychiatry. 1995 Jun 1;37(11):811-6.

PMID:
7647166
20.

Prevalence of seizure-precipitating drugs detected in chronic seizure patients in an ED.

Morgan DL, Baskin LB, Ahad GV, Orsulak PJ, Hayes JE.

Am J Emerg Med. 1995 Mar;13(2):251-2. No abstract available.

PMID:
7893325

Supplemental Content

Loading ...
Support Center